clarithromycin has been researched along with nab741 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
Hussain, Z; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L | 1 |
Hussain, Z; Li, L; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L; Yang, Y | 1 |
3 other study(ies) available for clarithromycin and nab741
Article | Year |
---|---|
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |
SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant
Topics: Animals; Antimicrobial Cationic Peptides; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2022 |
Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Microbial Sensitivity Tests | 2023 |